{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:09Z","timestamp":1791275769860,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030304020"],"award-info":[{"award-number":["2014A030304020"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.transproceed.2016.01.002","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T19:02:32Z","timestamp":1456167752000},"page":"3-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Sirolimus-Based Immunosuppressive Regimens in Renal Transplantation: A Systemic Review"],"prefix":"10.1016","volume":"48","author":[{"given":"D.Q.","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.Q.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2016.01.002_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ki.1996.28","article-title":"The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients","volume":"49","author":"Murgia","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2016.01.002_bib2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1097\/00007890-199911270-00016","article-title":"Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group","volume":"68","author":"Kahan","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. The Rapamune US Study Group","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2016.01.002_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A\u00a0worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib5","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0041-1345(03)00353-1","article-title":"Two-year results of multicenter phase III trials on the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal transplantation","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib6","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1097\/01.TP.0000062837.99400.60","article-title":"Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months","volume":"75","author":"Gonwa","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.tp.0000167757.63922.42","article-title":"A\u00a0prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 1 year","volume":"80","author":"Mendez","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000101290.20629.DC","article-title":"A\u00a0randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib9","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/01.TP.0000101495.22734.07","article-title":"A\u00a0randomized long-term trial of tacrolimus\/sirolimus versus tacrolimus\/mycophenolate mofetil versus cyclosporine (NEORAL)\/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year","volume":"77","author":"Ciancio","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib10","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.tp.0000203894.53714.27","article-title":"A\u00a0randomized long-term trial of tacrolimus\/sirolimus versus tacrolimums\/mycophenolate versus cyclosporine\/sirolimus in renal transplantation: three-year analysis","volume":"81","author":"Ciancio","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib11","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/TP.0b013e318187bab0","article-title":"Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial","volume":"86","author":"Gaber","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.transproceed.2005.01.045","article-title":"Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients","volume":"37","author":"Morales","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/01.TP.0000074360.62032.39","article-title":"Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of\u00a0the Rapamune Maintenance Regimen Study","volume":"76","author":"Oberbauer","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib15","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/01.ASN.0000113248.59077.76","article-title":"Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal","volume":"15","author":"Kreis","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.01.002_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1600-6143.2004.00446.x","article-title":"Sirolimus-based therapy\u00a0following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years","volume":"4","author":"Mota","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1432-2277.2004.00052.x","article-title":"Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation","volume":"18","author":"Oberbauer","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.01.002_bib18","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/00007890-200212150-00013","article-title":"Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination","volume":"74","author":"Gonwa","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1399-0012.2004.00113.x","article-title":"An open-label randomized trial of the safety and efficacy of sirolimus vs. azathioprine in living related renal allograft recipients receiving cyclosporine and prednisone combination","volume":"18","author":"Machado","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib20","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1590\/S0100-879X2004000900004","article-title":"Preservation of graft function in low-risk living kidney transplant recipients treated with a combination of sirolimus and cyclosporine","volume":"37","author":"Machado","year":"2004","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.transproceed.2016.01.002_bib21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1399-0012.2005.00331.x","article-title":"Concentration-controlled use of sirolimus associated with reduced exposure of cyclosporine in black recipients of primarily living renal allograft donors: 12-month results","volume":"19","author":"Ferreira","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/tri.12228","article-title":"The\u00a0efficacy and safety of cyclosporine reduction in de novo renal allograft patients receiving sirolimus and corticosteroids: results from an open-label comparative study","volume":"27","author":"Muhlbacher","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.01.002_bib23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1097\/01.TP.0000063703.32564.3B","article-title":"A\u00a0phase III prospective, randomized study to evaluate concentration-controlled sirolimus (rapamune) with cyclosporine dose minimization or elimination at six months in de novo renal allograft recipients","volume":"75","author":"Baboolal","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib24","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.transproceed.2010.02.083","article-title":"Comparison of the safety and efficacy of cyclosporine minimization versus cyclosporine elimination in de novo renal allograft patients receiving sirolimus","volume":"42","author":"Tedesco-Silva","year":"2010","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib25","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/01.TP.0000121504.69676.5E","article-title":"Comparison of sirolimus-based calcineurin inhibitor-sparing and calcineurin inhibitor-free regimens in cadaveric renal transplantation","volume":"77","author":"Lo","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib26","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1111\/j.1600-6143.2005.01064.x","article-title":"Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation","volume":"5","author":"Hamdy","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/039139880903200608","article-title":"Decreased acute rejection and improved renal allograft survival using sirolimus and low-dose calcineurin inhibitors without induction therapy","volume":"32","author":"Tsai","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.transproceed.2016.01.002_bib28","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1016\/j.transproceed.2011.10.052","article-title":"Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment","volume":"43","author":"Pliszczynski","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib29","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.transproceed.2013.03.025","article-title":"A\u00a0comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients","volume":"45","author":"Bechstein","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib30","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/00007890-199904150-00017","article-title":"Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group","volume":"67","author":"Groth","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib31","doi-asserted-by":"crossref","first-page":"58S","DOI":"10.1016\/S0041-1345(03)00213-6","article-title":"Bicetre hospital experience with sirolimus-based therapy in human renal transplantation: the Sirolimus European Renal Transplant Study","volume":"35","author":"Charpentier","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib32","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/00007890-200004150-00009","article-title":"Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients","volume":"69","author":"Kreis","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1034\/j.1600-6143.2002.20507.x","article-title":"Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients","volume":"2","author":"Morales","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib34","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/00007890-200210270-00002","article-title":"Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine","volume":"74","author":"Flechner","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib35","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1600-6143.2004.00627.x","article-title":"De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years","volume":"4","author":"Flechner","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.tp.0000258586.52777.4c","article-title":"Kidney transplantation with sirolimus and mycophenolate mofetil-based immunosuppression: 5-year results of a randomized prospective trial compared to calcineurin inhibitor drugs","volume":"83","author":"Flechner","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib37","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"Ekberg","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2016.01.002_bib38","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1111\/j.1600-6143.2009.02726.x","article-title":"Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation","volume":"9","author":"Ekberg","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib39","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/TP.0b013e3181db09e4","article-title":"Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids","volume":"89","author":"Glotz","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib40","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1111\/j.1600-6143.2011.03573.x","article-title":"The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients","volume":"11","author":"Flechner","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib41","first-page":"300","article-title":"Sirolimus versus calcineurin inhibitor-based immunosuppressive therapy in kidney transplantation: a 4-year follow-up","volume":"6","author":"Nafar","year":"2012","journal-title":"Iran J Kidney Dis"},{"key":"10.1016\/j.transproceed.2016.01.002_bib42","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/TP.0b013e318291a269","article-title":"A\u00a0randomized, open-label study of sirolimus versus cyclosporine in primary de novo renal allograft recipients","volume":"95","author":"Flechner","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/01.TP.0000128908.87656.28","article-title":"Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens","volume":"78","author":"McTaggart","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib44","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/j.transproceed.2009.08.049","article-title":"Conversion from calcineurin inhibitors to sirolimus in kidney transplant recipients: a retrospective cohort study","volume":"41","author":"Cardinal","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/TP.0b013e3181927a41","article-title":"Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial","volume":"87","author":"Schena","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib46","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1600-6143.2009.02615.x","article-title":"Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study","volume":"9","author":"Lebranchu","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib47","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1111\/j.1600-6143.2011.03637.x","article-title":"Efficacy and safety of early cyclosporine conversion to sirolimus with continued MMF-four-year results of the Postconcept study","volume":"11","author":"Lebranchu","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib48","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ki.2010.492","article-title":"Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial","volume":"79","author":"Weir","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2016.01.002_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/TP.0b013e3181e11798","article-title":"Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trial","volume":"90","author":"Guba","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib50","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1432-2277.2012.01432.x","article-title":"Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36months after transplantation","volume":"25","author":"Guba","year":"2012","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2016.01.002_bib51","doi-asserted-by":"crossref","first-page":"e75591","DOI":"10.1371\/journal.pone.0075591","article-title":"Deferred pre-emptive switch from calcineurin inhibitor to sirolimus leads to improvement in GFR and expansion of T regulatory cell population: a randomized, controlled trial","volume":"8","author":"Bansal","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2016.01.002_bib52","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.transproceed.2013.01.060","article-title":"Comparison of cyclosporine and sirolimus effects on serum creatinine level over five years after kidney transplantation","volume":"45","author":"Soleimani","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib53","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/08820139.2014.947033","article-title":"Long-term outcomes following sirolimus conversion after renal transplantation","volume":"43","author":"Soliman","year":"2014","journal-title":"Immunol Invest"},{"key":"10.1016\/j.transproceed.2016.01.002_bib54","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1111\/ajt.12481","article-title":"Planned randomized conversion from tacrolimus to sirolimus-based immunosuppressive regimen in de novo kidney transplant recipients","volume":"13","author":"Silva","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib55","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.transproceed.2008.07.070","article-title":"De\u00a0novo sirolimus-based regimen in Thai renal transplant recipients","volume":"40","author":"Townamchai","year":"2008","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib56","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1681\/ASN.V1251059","article-title":"Pharmacokinetic interactions augment toxicities of sirolimus\/cyclosporine combinations","volume":"12","author":"Podder","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2016.01.002_bib57","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1016\/j.transproceed.2005.07.044","article-title":"Observations on quadruple immunosuppression maintenance therapy using rapamycin, low-dose cyclosporine, mycophenolate mofetil, and prednisone following ATG induction","volume":"37","author":"Khauli","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5402\/2011\/536484","article-title":"Advantages of sirolimus in a calcineurin-inhibitor minimization protocol for the immunosuppressive management of kidney allograft recipients","volume":"2011","author":"Rahal","year":"2011","journal-title":"ISRN Immunol"},{"key":"10.1016\/j.transproceed.2016.01.002_bib59","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199810270-00013","article-title":"Immunosuppressive effects and safety of a sirolimus\/cyclosporine combination regimen for renal transplantation","volume":"66","author":"Kahan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib60","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0041-1345(00)02473-8","article-title":"Sirolimus permits steroid withdrawal from a cyclosporine regimen","volume":"33","author":"Mahalati","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib61","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.tp.0000173378.28790.0b","article-title":"Comparison of steroid avoidance in tacrolimus\/mycophenolate mofetil and tacrolimus\/sirolimus combination in kidney transplantation monitored by surveillance biopsy","volume":"80","author":"Anil Kumar","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.trim.2008.08.005","article-title":"Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes","volume":"20","author":"Anil Kumar","year":"2008","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.transproceed.2016.01.002_bib63","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1600-6143.2006.01340.x","article-title":"Long-term renal allograft function on a tacrolimus-based, pred-free maintenance immunosuppression comparing sirolimus vs. MMF","volume":"6","author":"Gallon","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib64","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1399-0012.2006.00613.x","article-title":"Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol","volume":"21","author":"Jaber","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib65","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1111\/j.1600-6143.2007.01976.x","article-title":"Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids","volume":"7","author":"Buchler","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib66","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s11255-011-0001-3","article-title":"Steroid or tacrolimus withdrawal in renal transplant recipients using sirolimus","volume":"43","author":"de Sandes Freitas","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.transproceed.2016.01.002_bib67","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/TP.0b013e31822805d7","article-title":"Results of a prospective randomized trial of sirolimus conversion in kidney transplant recipients on early corticosteroid withdrawal","volume":"92","author":"Heilman","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2016.01.002_bib68","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1600-6143.2012.04036.x","article-title":"Five-year results of a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation: the SPIESSER study","volume":"12","author":"Lebranchu","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2016.01.002_bib69","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.transproceed.2012.07.142","article-title":"High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study","volume":"44","author":"Burkhalter","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2016.01.002_bib70","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2215\/CJN.06940711","article-title":"Long-term kidney allograft function and survival in prednisone-free regimens: tacrolimus\/mycophenolate mofetil versus tacrolimus\/sirolimus","volume":"7","author":"Chhabra","year":"2012","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134516000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T21:36:26Z","timestamp":1654378586000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134516000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0041134516000038"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.002","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sirolimus-Based Immunosuppressive Regimens in Renal Transplantation: A Systemic Review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2016.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}